Toxicity of cytoreductive surgery and hyperthermic intra‐peritoneal chemotherapy

Cytoreduction with hyperthermic intra‐peritoneal chemotherapy (HIPEC) is a treatment with a high morbidity. Optimal patients selection can possible reduce toxicity and complications.

[1]  H. van Tinteren,et al.  Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  D. Jayne,et al.  Peritoneal carcinomatosis from colorectal cancer , 2002, The British journal of surgery.

[3]  M. Ducreux,et al.  Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy , 2001, Cancer.

[4]  F. van Coevorden,et al.  Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin. , 2001, European journal of cancer.

[5]  M. Manns,et al.  Improved prognosis following peritonectomy procedures and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from appendiceal carcinoma. , 2001, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[6]  B. Cesana,et al.  Obstructing colonic cancer: Failure and survival patterns over a ten-year follow-up after one-stage curative surgery , 2001, Diseases of the colon and rectum.

[7]  J. Talabard,et al.  Carcinoses péritonéales traitées par chirurgie de réduction tumorale et chimiohyperthermie intrapéritonéale , 2000 .

[8]  F. Gilly,et al.  Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis , 2000, Cancer.

[9]  K. Geisinger,et al.  Cytoreductive Surgery with Intraperitoneal Hyperthermic Chemotherapy for Disseminated Peritoneal Cancer of Gastrointestinal Origin , 2000, The American surgeon.

[10]  D. Giannarelli,et al.  Treatment of peritoneal carcinomatosis with intent to cure , 2000, Journal of surgical oncology.

[11]  J. Esquivel,et al.  Morbidity and Mortality Analysis of 200 Treatments With Cytoreductive Surgery and Hyperthermic Intraoperative Intraperitoneal Chemotherapy Using the Coliseum Technique , 1999, Annals of Surgical Oncology.

[12]  P. Sugarbaker,et al.  Results of Treatment of 385 Patients With Peritoneal Surface Spread of Appendiceal Malignancy , 1999, Annals of Surgical Oncology.

[13]  P. Sugarbaker,et al.  Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy , 1996, Cancer.

[14]  L. Laufman,et al.  Leucovorin plus 5-fluorouracil: an effective treatment for metastatic colon cancer. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  A. Russell,et al.  Adenocarcinoma of the colon: An autopsy study with implications for new therapeutic strategies , 1985, Cancer.

[16]  S. Fushida,et al.  Chemohyperthermic peritoneal perfusion for peritoneal dissemination in various intra-abdominal malignancies. , 1999, International surgery.

[17]  P. Sugarbaker,et al.  Second-look Surgery after Cytoreduction and Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Colorectal Cancer: Analysis of Prognostic Features , 1999, World Journal of Surgery.

[18]  B. Loggie,et al.  Complications of heated intraperitioneal chemotherapy and strategies for prevention. , 1996, Cancer treatment and research.